Nelson Peltz's activist investment firm Trian Fund Management has submitted two filings to the SEC recently.
First, per a Form 4 filed with the SEC, Trian Fund Management has increased its stake in Pentair (PNR). Per the filing, Trian acquired 265,000 shares on October 22nd at weighted average prices of between $54.7093 and $56.2684.
After these buys, Trian now owns over 13.27 million shares of PNR.
Second, per another Form 4, Peltz's firm has purchased 285,000 shares of Bank of New York Mellon (BK) on October 21st at a weighted average price of $41.3396. After these purchases, Trian now owns over 30.51 million shares of BK.
For more on this fund, we also posted up Trian's presentation on its new stake in General Electric.
Per Google Finance, Bank of New York Mellon is "a provider of financial products and services in domestic and international markets. Through its two principal businesses, Investment Management and Investment Services, it serves institutions, corporations and high net worth individuals. For institutions and corporations, it provides investment management, trust and custody, foreign exchange, fund administration, global collateral services, securities lending, depositary receipts, corporate trust, global payment/cash management, banking services and clearing services. For individuals, it provides mutual funds, separate accounts, wealth management and private banking services. BNY Mellon’s investment management businesses provide investment products in different asset classes and investment styles."
Per the company's website, Pentair is "a global water, fluid, thermal management, and equipment protection partner."
Tuesday, October 27, 2015
Nelson Peltz's activist investment firm Trian Fund Management has submitted two filings to the SEC recently.
Michael Blitzer's hedge fund firm Kingstown Capital has filed a 13D with the SEC regarding shares of Aerojet Rocketdyne (AJRD). Per the filing, Kingstown now owns 5.5% of the company with 3.5 million shares.
This is up slightly from the 3.4 million shares they owned at the end of the second quarter. The 13D filing contains the standard boilerplate that they purchased shares because they thought it was undervalued and they may talk to management from time to time.
We've posted previous portfolio activity from Kingstown here.
Per Google Finance, Aerojet Rocketdyne Holdings, Inc., formerly GenCorp, Inc., "is a manufacturer of aerospace and defense products and systems. The Company develops and manufactures propulsion systems for defense and space applications, and armaments for precision tactical and long-range weapon systems applications. It has two operating segments: Aerospace and Defense, and Real Estate. Its Aerospace and Defense segment includes the operations of its subsidiary Aerojet Rocketdyne, Inc., which is engaged in designing, developing and manufacturing aerospace and defense products and systems for the United States Government, including the United States Department of Defense (DoD), the National Aeronautics and Space Administration (NASA), aerospace and defense prime contractors, as well as portions of the commercial sector. Its real estate segment includes activities of its subsidiary Easton Development Company, LLC related to the re-zoning, entitlement, sale, and leasing of its excess real estate assets."
Broyhill Asset Management about a month ago penned research notes on shares of Time Warner (TWX). With all the talk of the content bundle coming apart, Broyhill sees downside risk around $65-70 per share, while TWX trades around $72 currently.
They take a look at the company's Turner division, Warner Brothers, HBO, and subscriber losses to outline the various risks in the investment.
They conclude that, "Putting it all together, we see $40B of value at Turner even assuming that accelerating subscriber losses result in significant earnings shortfalls and continued multiple compression. We see $20B of value at WB backed by attractive intellectual property and broader distribution driving pricing for content. At almost any reasonable multiple for HBO, we have a very difficult time justifying today’s $80B enterprise value of Time Warner even under very challenging assumptions."
Embedded below are Broyhill's research notes on Time Warner:
Monday, October 26, 2015
Point72 Asset Management's President Doug Haynes just appeared on Wall Street Week. Point72, of course, is Steve Cohen's latest investment vehicle after he closed SAC Capital. While SAC managed outside money, Point72 emerged as a family office to manage internal assets.
Point72's mission statement is threefold: to be the premier asset management firm (generate highest risk adjusted returns), have the highest ethical standards, and offer the best opportunities for the brightest talent.
Haynes said that the proliferation of hedge funds has really ratcheted up competitiveness in the market and has also increased crowding. He mentioned they looked at the amount of alpha available and over the last 20 years it's down by half. He notes, "The cost of being excellent in the industry keeps going up."
We previously linked to how Point72 has started an academy for analysts.
Haynes said that they like the healthcare sector and retail/consumer sectors now. He notes they're looking at the innovation pieces of the economy.
Embedded below is the video of Haynes' interview on Wall Street Week:
Be sure to also check out Donald Drapkin's appearance on Wall Street Week as well as Ricky Sandler's interview.
Oaktree Capital's Chairman Howard Marks has released his latest memo. It is entitled "Inspiration from the World of Sports" and obviously highlights the parallels between investing and sports.
This is a concept Marks has touched on before, where he talked about how they're similar: both competitive, both quantitative (can see results), meritocracies, team-oriented, and satisfying when you win.
Tiger Management's Julian Robertson has identified competitiveness as one of the top attributes he looks for in hedge fund managers.
Other similarities can be made when comparing poker to investing/trading as well.
In the end, Marks concludes that one of the key lessons from sports is that, "For most participants, success is likely to lie more dependably in discipline, consistency and minimization of error, rather than in bold strokes - high batting average and an absence of strikeouts, not the occasional, sensational home run."
Embedded below is Marks' latest memo, "Inspiration from the World of Sports:
You can download a .pdf copy here.
For more from this manager, head to Mark's memo on
Larry Robbins' hedge fund firm Glenview Capital has made numerous portfolio adjustments recently. Below are the details of the various SEC filings they've made.
Increases FMC Position
Glenview has filed a 13G with the SEC on shares of FMC Corporation (FMC). Per the filing, Glenview now owns 5.01% of the company with over 6.69 million shares.
This is up from the 4.8 million shares they owned at the end of the second quarter. The filing was made due to activity on October 12th.
Per Google Finance, FMC is "a diversified chemical company. The Company serves agricultural, consumer and industrial markets with solutions, applications and products around the world. The Company operates in three business segments: FMC Agricultural Solutions, FMC Health and Nutrition, and FMC Lithium. The Company's FMC Agricultural Solutions segment develops, markets and sells three classes of crop protection chemicals, which include insecticides, herbicides and fungicides. The FMC Health and Nutrition segment focuses on food, pharmaceutical ingredients, nutraceuticals, personal care and similar markets. The pharmaceutical additives are used for binding, encapsulation and disintegrant applications. The Company's FMC Lithium segment manufactures lithium products."
Reduces Flextronics Exposure
Second, the hedge fund has also filed a Form 4 with the SEC regarding its position in Flextronics (FLX). Per the filing, Glenview sold 20 million shares at $11.1 on October 22nd. After this transaction, they still own 55.13 million shares.
Per Google Finance, Flextronics is "a Singapore-based provider of global supply chain solutions. The Company designs, builds, ships and serves packaged electronic products for its original equipment manufacturers (OEMs) in various groups. The Company offers a range of design and engineering services that relate to manufacturing (including enclosures, metals, plastic injection molding, precision plastics, machining, and mechanicals), system integration and assembly and test services, materials procurement, inventory management, logistics and after-sales services (including product repair, warranty services, re-manufacturing and maintenance), supply chain management software solutions and component product offerings (including rigid and flexible printed circuit boards and power adapters and chargers)."
Trims Community Health Systems Stake
Third, Larry Robbins' hedge fund has filed a Form 4 with the SEC indicating they've reduced their stake in Community Health Systems (CYH). Per the filing, Glenview sold 279,074 shares on October 22nd at weighted average prices of $27.7284 and $26.8947 with about a third of the sales occurring at $30.08.
After these sales, Glenview still owns 11.81 million shares of CYH.
Per Google Finance, Community Health Systems is "a hospital company and an operator of acute care hospitals in communities across the United States. The Company provides healthcare services through the hospitals that it owns and operates in non-urban and selected urban markets throughout the United States. It operates in two operating segments: hospital operations and home care agencies operations. Its hospital operations include the Company's acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services. Its home care agencies operations provide in-home outpatient care. Services provided through its hospitals and affiliated businesses include general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric and rehabilitation services. It provides a range of hospital healthcare services and other outpatient services to patients in the communities in which the Company is located.."
Adds to Tenet Healthcare Position
Last, Glenview also increased its holdings of Tenet Healthcare (THC). Per a Form 4 filed with the SEC, Glenview acquired 500,000 shares total on October 22nd at weighted average prices of $28.8656 and $29.8034. After these buys, Glenview now owns over 16.99 million shares of THC. As we've detailed previously, Glenview has previously been out buying THC in October.
Per Google Finance, Tenet Healthcare is "a healthcare services company. The Company operates regionally focused, integrated healthcare delivery networks in large urban and suburban markets. As of December 31, 2014, it operated 80 hospitals, 210 outpatient centers, six health plans and Conifer Health Solutions, LLC (Conifer), which provides healthcare business process services in the areas of revenue cycle management, value-based care and patient communications. It provides operational management for revenue cycle functions, including patient access, health information management, revenue integrity and patient financial services. It also offers communications and engagement solutions to optimize the relationship between providers and patients. Conifer operates a management services business that supports value-based performance through clinical integration, financial risk management and population health management. It has two operating segments: Hospital Operations and other, and Conifer.."